Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection

Early Measurement of Blood sST2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for COVID-19 Infection

Although several biomarkers have shown correlation to prognosis in COVID-19 patients, their clinical value is limited because of lack of specificity, suboptimal sensibility or poor dynamic behavior. We hypothesized that circulating soluble ST2 (sST2) could be associated to a worse outcome in COVID-1...

Full description

Bibliographic Details
Main Authors: Marta Sánchez-Marteles, Jorge Rubio-Gracia, Natacha Peña-Fresneda, Vanesa Garcés-Horna, Borja Gracia-Tello, Luis Martínez-Lostao, Silvia Crespo-Aznárez, Juan Ignacio Pérez-Calvo, Ignacio Giménez-López
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
soluble ST2
biomarker
COVID-19
prognosis
lung injury
Online Access:https://www.mdpi.com/2077-0383/10/16/3534

Internet

https://www.mdpi.com/2077-0383/10/16/3534

Similar Items